Tivona Capital | Parrot Pharmaceuticals
4735
portfolio_page-template-default,single,single-portfolio_page,postid-4735,ajax_fade,page_not_loaded,,wpb-js-composer js-comp-ver-4.1.2,vc_responsive

Parrot Pharmaceuticals

CATEGORY
Biotech
ABOUT

Parrot was the Canadian over-the-counter division of Arrow Pharmaceuticals/ Cobalt Pharmaceuticals. Arrow Pharmaceuticals was sold to Watson Pharmaceuticals in June 2009 for over US$1.75 Billion.